Skip to main content
Clinical Trials/NCT07530991
NCT07530991
Active, not recruiting
Not Applicable

Registry Analysis of Deceased Donor Kidney Transplant Outcomes With Normothermic Machine Perfusion (NMP)

Chris Jaynes1 site in 1 country3,500 target enrollmentStarted: April 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Chris Jaynes
Enrollment
3,500
Locations
1
Primary Endpoint
Delayed Graft Function

Overview

Brief Summary

This study uses existing transplant data obtained from a national public donor registry operated by the Organ Procurement and Transplant Network (OPTN) under Health Resources and Services Agency (HRSA) to evaluate outcomes associated with normothermic machine perfusion (NMP) of deceased donor kidneys. Currently, there is no method to study NMP kidney outcomes using the National Scientific Registry for Transplant Recipients (SRTR) national public registry, because no data field exists to identify which kidneys received NMP.

Detailed Description

This is a retrospective observational study using existing data from the Scientific Registry of Transplant Recipients (SRTR)/ Organ Procurement and Transplant Network (OPTN) public registry following a Research Plan approved by Health Resources & Services Agency (HRSA).

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Ages
15 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Requires kidney transplantation

Exclusion Criteria

  • \> 15 years old

Arms & Interventions

NMP Kidney Recipients

Patients receiving a kidney preserved and assessed using NMP

Outcomes

Primary Outcomes

Delayed Graft Function

Time Frame: 7 days post-transplantation

Requirement for dialysis immediately post kidney transplantation

Delayed Graft Function (DGF)

Time Frame: 7 days

Requirement for dialysis within 7 days post kidney transplantation

Secondary Outcomes

  • Serum creatinine(Up to 3 years post-transplantation)

Investigators

Sponsor
Chris Jaynes
Sponsor Class
Industry
Responsible Party
Sponsor Investigator
Principal Investigator

Chris Jaynes

PI, co-CEO

34 Lives, PBC

Study Sites (1)

Loading locations...

Similar Trials